Intranasal Corticosteroids for the Treatment of Perennial Allergic Rhinitis

2007 ◽  
Vol 100 (7) ◽  
pp. 667-668
Author(s):  
Jeff Stokes
Keyword(s):  
Allergic Rhinitis ◽  
Perennial Allergic Rhinitis ◽  
Intranasal Corticosteroids

Intranasal Ciclesonide in Allergic Rhinitis

2010 ◽  
Vol 2 ◽  
pp. CMT.S4120
Author(s):  
Harissios Vliagoftis
Keyword(s):  
Quality Of Life ◽  
Allergic Rhinitis ◽  
Indirect Costs ◽  
Pharmacokinetic Profile ◽  
Improve Quality ◽  
Perennial Allergic Rhinitis ◽  
Direct And Indirect Costs ◽  
Intranasal Corticosteroids ◽  
Very High

Allergic rhinitis affects more than 20% and is responsible for very high direct and indirect costs. Nasal corticosteroids are the principle pharmaceutical option for the treatment of allergic rhinitis. They are more effective than all other therapeutic options and in addition to improving symptoms of allergic rhinitis they also improve quality of life in patients suffering from allergic rhinitis. There are many intranasal corticosteroids approved for the treatment of allergic rhinitis in pediatric and adult populations. Ciclesonide has shown so far a very good safety and pharmacokinetic profile and is effective for treatment of symptoms in both seasonal and perennial allergic rhinitis. This review summarizes the studies describing these effects of intranasal ciclesonide.

Intranasal Corticosteroids, Inflammation, and Symptoms in Allergic Rhinitis

1999 ◽  
Vol 11 (1) ◽  
pp. 0004-0010 ◽  
Author(s):  
Niels Mygind ◽  
Lars Nielsen ◽  
Hans-Jürgen Hoffmann ◽  
Ronald Dahl ◽  
Henrik Jacobi
Keyword(s):  
Allergic Rhinitis ◽  
Intranasal Corticosteroids

The effectiveness of therapies perennial allergic rhinitis associated with fungi of the genus of Candida, in children

2016 ◽  
Vol 18 (3) ◽  
pp. 100-103
Author(s):  
T.G. Malanicheva ◽  
◽  
N.V. Ziatdinova ◽  
L.F. Akhmadieva ◽  
◽  
...  
Keyword(s):  
Allergic Rhinitis ◽  
Perennial Allergic Rhinitis

scholarly journals MP-AzeFlu in Moderate-to-Severe Allergic Rhinitis: A Literature Review

2021 ◽  
pp. 1-10
Author(s):  
Ludger Klimek ◽  
William E. Berger ◽  
Jean Bousquet ◽  
Paul K. Keith ◽  
Peter Smith ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Allergic Rhinitis ◽  
Fluticasone Propionate ◽  
Treatment Options ◽  
Symptomatic Disease ◽  
Intranasal Corticosteroids ◽  
Need For Treatment ◽  
Ocular Symptoms ◽  
Symptom Complex

Allergic rhinitis (AR) is prevalent, and many patients present with moderate-to-severe symptomatic disease. The majority of patients are not satisfied with their AR treatment, despite the use of concurrent medications. These gaps underscore the need for treatment with more effective options for moderate-to-severe AR. The authors’ objective was to review systematically the efficacy and safety of MP-AzeFlu for the treatment of AR. The primary outcomes studied were nasal, ocular, and total symptoms. Other outcomes included time to onset and of AR control, quality of life, and safety. Searches of PubMed and Cochrane databases were conducted on May 14, 2020, with no date restrictions, to identify publications reporting data on MP-AzeFlu. Clinical studies of any phase were included. Studies were excluded if they were not in English, were review articles, did not discuss the safety and efficacy of MP-AzeFlu for AR symptoms. Treatment of AR with MP-AzeFlu results in effective, sustained relief of nasal and ocular symptoms, and faster onset and time to control compared with intranasal azelastine or fluticasone propionate. Long-term use of MP-AzeFlu was safe, with benefits in children, adults, and adults aged ≥65 years. Other treatment options, including fluticasone propionate and azelastine alone or the combination of intranasal corticosteroids and oral antihistamine, do not provide the same level of efficacy as MP-AzeFlu in terms of rapid and sustained relief of the entire AR symptom complex. Furthermore, MP-AzeFlu significantly improves patient quality of life. MP-AzeFlu is a currently available combination that may satisfy all these patient needs and expectations.

Sign in / Sign up

Export Citation Format

Share Document